An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...

A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more ...

A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...